FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Nystatin 100000 unit oromucosal lozenge Has presentation strength denominator value False un Inferred relationship Some 1
    Nystatin 100000 unit oromucosal lozenge Count of base of active ingredient False un Inferred relationship Some
    Nystatin 100000 unit vaginal tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Nystatin 100000 unit vaginal tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely tuberculin purified protein derivative 10 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely tuberculin purified protein derivative 10 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Tuberculin purified protein derivative 1000 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Tuberculin purified protein derivative 1000 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely follitropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely follitropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely follitropin alfa 37.5 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely follitropin alfa 37.5 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely tuberculin purified protein derivative 100 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely tuberculin purified protein derivative 100 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection Has concentration strength denominator value False un Inferred relationship Some 2
    Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection Count of base of active ingredient False un Inferred relationship Some
    Tuberculin purified protein derivative 50 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Tuberculin purified protein derivative 50 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely colistin 1.5 million unit/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely colistin 1.5 million unit/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely interferon alfa-n3 5 million unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely interferon alfa-n3 5 million unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Follitropin alfa 300 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Follitropin alfa 300 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Urofollitropin 150 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Urofollitropin 150 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Epoetin alfa 20000 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Epoetin alfa 20000 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely bemiparin sodium 22500 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely bemiparin sodium 22500 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Bemiparin sodium 40000 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Bemiparin sodium 40000 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Antidiuretic hormone 20 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Antidiuretic hormone 20 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Benzathine benzylpenicillin 600000 unit/mL suspension for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Benzathine benzylpenicillin 600000 unit/mL suspension for injection Count of base of active ingredient False un Inferred relationship Some
    Urokinase 50000 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Urokinase 50000 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Bovine isophane insulin 100 unit/mL suspension for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Bovine isophane insulin 100 unit/mL suspension for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    RimabotulinumtoxinB 5000 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    RimabotulinumtoxinB 5000 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Human anti-D immunoglobulin 1250 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Human anti-D immunoglobulin 1250 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely fluvoxamine maleate 150 milligram/1 each prolonged-release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely fluvoxamine maleate 150 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 3
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Fluvoxamine maleate 100 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Fluvoxamine maleate 100 mg prolonged-release oral capsule Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 3
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2

    Start Previous Page 187 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start